照光治療設備市場 - 全球產業規模、佔有率、趨勢、機會、預測：按產品、應用、最終用途、地區和競爭對手分類，2021-2031年

全球照光治療設備市場預計將從 2025 年的 4.9101 億美元成長到 2031 年的 6.7242 億美元，複合年成長率為 5.38%。

這些醫療設備利用特定波長的光，包括紫外線和螢光光源，來治療多種皮膚疾病，例如乾癬、白斑和新生兒黃疸。該市場的成長主要受慢性皮膚病患病率上升以及對有效、非侵入性治療方法（尤其是嬰幼兒治療）的迫切需求的驅動。此外，人們對更經濟的全身性用藥治療方法的需求不斷成長，也進一步推動了照光治療設備在臨床和居家照護中的應用。然而，該市場面臨的主要挑戰是紫外線照射可能帶來的長期安全隱患，包括紅斑和皮膚惡性腫瘤的風險，這些都可能降低患者的依從性。儘管患者群體龐大——根據美國皮膚病學會估計，到2025年，美國成年人中將有3.0%患有銀屑病——但這些安全隱患阻礙了照光治療解決方案的廣泛應用，儘管其需求十分迫切。

市場促進因素

全球照光治療設備市場的主要促進因素是慢性皮膚病在全球範圍內的日益普遍。隨著異位性皮膚炎和銀屑病等自體免疫疾病的盛行率上升，人們照光治療作為一種重要的非藥物療法的依賴性也日益增強。國際皮膚病學會聯盟（ILDS）在《皮膚過敏雜誌》（Skin Allergy Journal）上發表的一份報告顯示，到2025年2月，全球預計將有2.04億人患有異位性皮膚炎，如此龐大的患者群體推動了皮膚科診所照光治療設備的持續需求，以應對疾病的急性發作。此外，美國國家乾癬基金會2025年1月的數據顯示，79.3%的乾癬患者病情未得到緩解，顯示相當一部分患者的病情控制不佳。這種情況凸顯了照光治療等有效治療方法的迫切需求，以改善臨床療效，從而進一步提升了市場潛力。同時，醫療專業人員照光治療有效性的認知不斷提高，推動了先進設備的廣泛應用。由於靶向照光治療相比全身用藥具有更高的安全性和療效，皮膚科醫生越來越傾向於採用這種療法，從而提高了設備的運轉率。領先技術供應商的業績數據也印證了這個趨勢。例如，Strata Skin Sciences公司在2025年3月報告稱，其XTRAC系統在2024年第四季在美國的平均淨銷售額達到5906美元，較去年同期成長6%。這些數據表明，隨著臨床醫生認知到光療的治療益處，現有照光治療設備的利用率將會提高，從而提升市場價值並促進其更廣泛的應用。

市場挑戰

照光治療設備市場面臨的主要阻礙因素之一是紫外線 (UV) 照射可能帶來的長期安全風險。臨床上對副作用的擔憂，尤其是紅斑和皮膚惡性腫瘤風險的增加，導致醫護人員和患者都對此持謹慎態度。這種擔憂直接影響了照光治療設備的普及率，因為患者通常傾向於避免可能加劇原有健康問題的治療。因此，人們越來越傾向於選擇生物製藥和其他避免輻射暴露的全身療法，這給設備製造商帶來了競爭障礙。監管機構和醫療機構不斷強調累積紫外線照射與皮膚損傷之間的聯繫，進一步阻礙了市場成長。最新的皮膚疾病健康數據也支持此風險。例如，皮膚癌基金會估計，2024 年美國將診斷出 200,340 例惡性黑色素瘤病例。這些統計數據凸顯了照光治療中嚴格安全規程的必要性，這增加了診所的行政負擔，並限制了這些設備在慢性皮膚病治療中的廣泛應用。

市場趨勢

隨著居家治療方案的普及，醫療服務場所正從臨床環境轉向家庭環境。這一趨勢主要得益於攜帶式、易用型設備的研發，這些設備使患者能夠在家中管理諸如銀屑病等慢性疾病，從而減少頻繁的門診就診。近期臨床數據有力地支持了這一轉變，這些數據表明遠端醫療的療效與門診治療相當。例如，根據美國皮膚病學會於2024年3月發布的“照光治療療效（LITE）研究”，接受居家照光治療的患者中有32.8%在12週內達到“皮膚完全清除”或“接近完全清除”的效果，高於接受門診治療的患者的25.6%。這種療效不劣於門診治療的證據正在加速居家設備作為主要治療方案的廣泛接受度。同時，市場正將關注點從傳統的醫療疾病擴展到美容和痤瘡治療等領域。製造商正加速推動解決美容問題的設備商業化，從而惠及更多對非侵入性活膚和有效治療痤瘡感興趣的患者。結合醫學皮膚科和美容療法的專業技術的商業性擴張，清晰地展現了這種多元化趨勢。正如Strata Skin Sciences在2024年5月報告的那樣，其專有的TheraClear® X光穴位痤瘡治療系統在美國國內的安裝量已超過100台，這表明市場對兼具美容功效且高度靈活的照光治療解決方案的需求日益成長。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球照光治療設備市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 產品類別（傳統照光治療設備、LED照光治療設備、光纖照光治療設備）
  • 透過外用（治療皮膚病、乾癬、白斑、濕疹等）
  • 依最終用途（醫院/診所、居家照護、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美照光治療設備市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲照光治療設備市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區照光治療設備市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲照光治療設備市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲照光治療設備市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章 全球照光治療設備市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Signify Holding
• GE Healthcare
• Natus Medical Incorporated
• Hebert Waldmann GmbH & Co. KG
• Nice Neotech Medical Systems Pvt. Ltd.
• Atom Medical Corporation
• Phoenix Medical Systems Pvt. Ltd.
• National Biological Corp.
• Solarc Systems Inc.
• The Daavlin Company

第16章 策略建議

第17章：關於研究公司及免責聲明

The global phototherapy equipment market is projected to expand from USD 491.01 Million in 2025 to USD 672.42 Million by 2031, exhibiting a compound annual growth rate of 5.38%. These medical devices use specific light wavelengths, including ultraviolet and fluorescent sources, to treat various dermatological conditions like psoriasis, vitiligo, and neonatal jaundice. This market growth is primarily driven by the increasing prevalence of chronic skin conditions and the crucial need for effective, non-invasive therapies, especially for infants. Additionally, the increasing demand for economical treatment options, serving as alternatives to systemic medications, further boosts the adoption of phototherapy devices in both clinical and home care environments. However, a key challenge for the market involves the potential long-term safety concerns linked to ultraviolet radiation exposure, such as erythema and the risk of skin malignancy, which could reduce patient compliance. Despite a significant patient pool, with psoriasis affecting an estimated 3.0 percent of U.S. adults in 2025, as reported by the American Academy of Dermatology, these safety apprehensions hinder the wider adoption of phototherapy solutions, despite their critical necessity.

Market Driver

A primary driver for the Global Phototherapy Equipment Market is the increasing global incidence of chronic dermatological conditions. The growing prevalence of autoimmune disorders such as atopic dermatitis and psoriasis elevates the dependence on phototherapy as an essential non-pharmacological treatment. With atopic dermatitis affecting an estimated 204 million people worldwide by February 2025, as reported by the International League of Dermatological Societies in the Skin Allergy Journal, a substantial patient demographic fuels the ongoing demand for phototherapy units in dermatology clinics for managing disease flare-ups. Furthermore, the market potential is amplified by the significant number of patients with uncontrolled conditions, evidenced by National Psoriasis Foundation data from January 2025 showing that 79.3 percent of psoriasis patients were not in remission, highlighting the critical need for effective therapies like light therapy to enhance clinical results. Concurrently, greater awareness among healthcare professionals regarding phototherapy's effectiveness is driving increased utilization of advanced equipment. Dermatologists are increasingly favoring targeted light treatments due to their favorable safety profile and efficacy compared to systemic medications, which boosts device productivity. This trend is corroborated by performance data from key technology providers; for instance, Strata Skin Sciences reported in March 2025 that the average net revenue per domestic XTRAC system rose to $5,906 in Q4 2024, marking a 6 percent year-over-year increase. Such figures demonstrate that as clinicians recognize the therapeutic advantages, the usage intensity of existing phototherapy infrastructure increases, thereby enhancing market value and fostering broader adoption.

Market Challenge

A significant restraint for the phototherapy equipment market stems from the potential long-term safety risks linked to ultraviolet radiation exposure. Clinical worries about side effects, particularly erythema and an increased risk of skin malignancy, lead to reluctance among both healthcare providers and patients. This apprehension directly influences the adoption rates of phototherapy devices, as patients frequently prefer to avoid treatments that might worsen their existing health concerns. As a result, the growing preference for biological drugs or other systemic alternatives that bypass radiation exposure establishes a competitive hurdle for device manufacturers. Regulatory authorities and medical organizations consistently highlight the connection between cumulative UV exposure and skin damage, which further impedes market growth. This risk is supported by current health data on skin pathologies; for example, the Skin Cancer Foundation estimated 200,340 melanoma cases were diagnosed in the United States in 2024. These statistics underscore the need for stringent safety protocols in phototherapy, subsequently increasing the administrative load on clinics and restricting the broad application of these devices for managing chronic skin conditions.

Market Trends

The increasing availability of home-based treatment solutions is shifting healthcare delivery from clinical settings to domestic environments. This trend is fueled by the creation of portable, user-friendly devices that enable patients to privately manage chronic conditions such as psoriasis, thereby reducing the necessity for frequent clinic visits. This transition is strongly supported by recent clinical data indicating that the effectiveness of remote treatment is comparable to in-office procedures. For instance, the American Academy of Dermatology's 'Light Treatment Effectiveness (LITE) study' in March 2024 reported that 32.8 percent of patients undergoing home phototherapy achieved clear or almost clear skin within 12 weeks, surpassing the 25.6 percent seen in those receiving office-based treatments. This evidence of non-inferiority is accelerating the broader acceptance of home units as a primary therapeutic choice. Concurrently, the market is broadening its focus beyond conventional medical pathology to include aesthetic and acne treatment applications. Manufacturers are increasingly commercializing devices tailored for cosmetic concerns, thereby reaching a wider patient base interested in non-invasive skin rejuvenation and effective management of active acne. This diversification is clearly demonstrated by the commercial expansion of specialized technologies that integrate medical dermatology with aesthetics. As reported by Strata Skin Sciences in May 2024, the installed base of its proprietary TheraClear(R)X photo-pneumatic acne treatment system exceeded 100 units domestically, showcasing the growing market demand for adaptable phototherapy solutions that offer aesthetic benefits.

Key Market Players

• Signify Holding
• GE Healthcare
• Natus Medical Incorporated
• Hebert Waldmann GmbH & Co. KG
• Nice Neotech Medical Systems Pvt. Ltd.
• Atom Medical Corporation
• Phoenix Medical Systems Pvt. Ltd.
• National Biological Corp.
• Solarc Systems Inc.
• The Daavlin Company

Report Scope

In this report, the Global Phototherapy Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Phototherapy Equipment Market, By Product

• Conventional Phototherapy Equipment
• LED Phototherapy Equipment
• Fiber Optic Phototherapy Equipment

Phototherapy Equipment Market, By Application

• Skin Diseases Treatment
• Psoriasis
• Vitiligo
• Eczema
• others

Phototherapy Equipment Market, By End-use

• Hospitals & Clinics
• Homecare
• Others

Phototherapy Equipment Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Phototherapy Equipment Market.

Available Customizations:

Global Phototherapy Equipment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Phototherapy Equipment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Conventional Phototherapy Equipment, LED Phototherapy Equipment, Fiber Optic Phototherapy Equipment)
  • 5.2.2. By Application (Skin Diseases Treatment, Psoriasis, Vitiligo, Eczema, others)
  • 5.2.3. By End-use (Hospitals & Clinics, Homecare, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Phototherapy Equipment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End-use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Phototherapy Equipment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-use
  • 6.3.2. Canada Phototherapy Equipment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-use
  • 6.3.3. Mexico Phototherapy Equipment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-use

7. Europe Phototherapy Equipment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End-use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Phototherapy Equipment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-use
  • 7.3.2. France Phototherapy Equipment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-use
  • 7.3.3. United Kingdom Phototherapy Equipment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-use
  • 7.3.4. Italy Phototherapy Equipment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-use
  • 7.3.5. Spain Phototherapy Equipment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-use

8. Asia Pacific Phototherapy Equipment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End-use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Phototherapy Equipment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-use
  • 8.3.2. India Phototherapy Equipment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-use
  • 8.3.3. Japan Phototherapy Equipment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-use
  • 8.3.4. South Korea Phototherapy Equipment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-use
  • 8.3.5. Australia Phototherapy Equipment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-use

9. Middle East & Africa Phototherapy Equipment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End-use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Phototherapy Equipment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-use
  • 9.3.2. UAE Phototherapy Equipment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-use
  • 9.3.3. South Africa Phototherapy Equipment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-use

10. South America Phototherapy Equipment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End-use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Phototherapy Equipment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-use
  • 10.3.2. Colombia Phototherapy Equipment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-use
  • 10.3.3. Argentina Phototherapy Equipment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Phototherapy Equipment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Signify Holding
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. GE Healthcare
• 15.3. Natus Medical Incorporated
• 15.4. Hebert Waldmann GmbH & Co. KG
• 15.5. Nice Neotech Medical Systems Pvt. Ltd.
• 15.6. Atom Medical Corporation
• 15.7. Phoenix Medical Systems Pvt. Ltd.
• 15.8. National Biological Corp.
• 15.9. Solarc Systems Inc.
• 15.10. The Daavlin Company

16. Strategic Recommendations

17. About Us & Disclaimer